Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS for adults with asthma

Overview of attention for article published in this source, November 2014

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma

Article in Cochrane Database of Systematic Reviews (August 2015)

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma

Article in Cochrane Database of Systematic Reviews (July 2015)

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta<sub>2</sub>‐agonists (LABA) for adults with asthma

Article in Cochrane Database of Systematic Reviews (June 2015)